Clinical trial
Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomized, Double Blind Placebo Controlled, Parallel, Groups Study
NCT02704091 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults. A Multicentre, Randomized, Double Blind Placebo Controlled, Parallel, Groups Study
- Lead sponsor
- Ipsen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 17, 2016
- Completion date
- April 8, 2019
- Enrollment
- 858 (actual)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.
acute diarrhoea